Stay updated with breaking news from Early Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- LYBALVI Demonstrated Less Weight Gain Compared to Olanzapine in Patients With Schizophrenia, Schizophreniform Disorder or Bipolar I Disorder - DUBLIN, Feb. 8, 2022 /PRNewswire/ -- Alkermes
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced positive topline results from ENLIGHTEN-Early, a phase 3b study that evaluated the effect of...
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced positive topline results from ENLIGHTEN-Early, a phase 3b study that evaluated the effect of...
The Omicron variant battle is heating up, and Canadian tech company Ti-DOX hopes to use their new machine to control its spread.
Here’s what you need to know about how this experimental treatment was developed, how it works, and its potential to improve life for people with type 1 diabetes, according to diabetes experts.